Cargando...
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma is a frequent and poor prognosis tumor, with most patients facing up, soon or later, to systemic therapies. So far, systemic therapies based on tyrosine kinase inhibitor monotherapies have been of modest benefit. The aim of this review article was to characte...
Gardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826922/ https://ncbi.nlm.nih.gov/pubmed/33440630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020238 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|